{"product_id":"uscap-updates-from-the-new-who-classification-of-soft-tissue-and-bone-tumors-2020-cme-videos","title":"USCAP Updates from the New WHO Classification of Soft Tissue and Bone Tumors 2020 (CME VIDEOS)","description":"\u003cp\u003eUSCAP Updates from the New WHO Classification of Soft Tissue and Bone Tumors 2020 (CME VIDEOS)\u003c\/p\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eCourse Description\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cdiv class=\"single-main-content\"\u003e\n\u003cp\u003eThe diagnosis of soft tissue and bone tumors can be a significant challenge, even to the experienced surgical pathologist, due to the rarity of such tumors, the broad morphological spectrum of mesenchymal neoplasms, and overlap with other soft tissue and bone tumors and non-mesenchymal neoplasms. The classification of soft tissue and bone tumors continues to evolve, following the description of “new” tumor types, the discovery of novel molecular genetic alterations, and the development of increasingly specific diagnostic immunohistochemical markers; these changes are included in the new World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone.\u003c\/p\u003e\n\u003cp\u003eSurgical pathologists are not familiar with the current classification of soft tissue and bone tumors and recently developed diagnostic markers and struggle with accurate diagnosis. This course, presented by experts, will help to alleviate that struggle and provide pragmatic information for immediate practice improvement.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003ePracticing academic and community pathologists, and pathologists-in-training\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\nReview update in soft tissue and bone tumors based on the new WHO classification\u003cbr\u003e\nApply recently developed immunohistochemical markers for the diagnosis of soft tissue and bone tumors\u003cbr\u003e\nUnderstand the role of recently identified molecular genetic alterations in the diagnosis of soft tissue and bone tumors\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eTopics: \u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBone Tumors\u003c\/li\u003e\n\u003cli\u003eVascular Tumors, Smooth Muscle Tumors, So-Called Fibrohistiocytic Tumors, and Gastrointestinal Stromal Tumors\u003c\/li\u003e\n\u003cli\u003eAdipocytic Tumors, Peripheral Nerve Sheath Tumors, and Tumors of Uncertain Differentiation\u003c\/li\u003e\n\u003cli\u003eFibroblastic and Myofibroblastic Tumors, Skeletal Muscle Tumors, and Undifferentiated Round Cell Sarcomas\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eOriginal release date: \u003c\/strong\u003e \u003cspan style=\"color: #ff0000\"\u003e\u003cstrong\u003eApril 1, 2020\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003e\n\u003cstrong\u003eAccess to this course expires on:\u003cspan style=\"color: #ff0000\"\u003e December 6, 2022\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954657693794,"sku":"MED-AMB07678","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/USCAP-Updates-from-the-New-WHO-Classification-of-Soft-Tissue.png?v=1779381816","url":"https:\/\/meducourse.com\/products\/uscap-updates-from-the-new-who-classification-of-soft-tissue-and-bone-tumors-2020-cme-videos","provider":"Meducourse","version":"1.0","type":"link"}